MY ACCOUNT | NEWSLETTER |

Respond Systems Unveils New Identity Reflecting the Company’s Deep Dedication to Animal Rehabilitation


Respond Systems, a trusted leader in animal health technology, is now Respond Animal Therapeutics, a name that more accurately reflects their comprehensive approach to animal health by offering innovative and restorative solutions that support wellness, prevention, recovery, and healing—helping animals thrive at every stage of life. The evolution of their identity, which is also reflected in a new logo and website, honors their decades of experience in the animal wellness industry and highlights their role and purpose in the recovery and rehabilitation process.

Founded in 1983, Respond Animal Therapeutics was a pioneer in offering laser therapy and pulsed electromagnetic field (PEMF) therapy to the equine industry and later to the pet industry. Made in the United States, Respond Animal Therapeutics delivers an integrated ecosystem of advanced, proven technologies that offer holistic therapies designed to enhance cellular repair, accelerate healing, and effectively manage pain, providing a cutting-edge alternative to more invasive treatments.

Respond Animal Therapeutics was acquired in 2022 by Paw Prosper, a pet health and wellness portfolio that offers a one-stop shop for efficacious solutions to larger pet wellness issues. Both entities are committed to providing innovative, personalized support for every animal, and the strategic acquisition has enabled Respond to leverage Paw Prosper’s resources and expertise to further its mission to help animals heal smarter.

This rebrand was crafted to highlight the balance of human ingenuity and trusted technology that makes the company unique. The logo’s design, with a feeling of movement and a hint at infinity, symbolizes the continuous nature of healing and recovery. Clean and dynamic, it reflects the ease and efficiency of Respond's products. The rounded shape conveys approachability and friendliness, setting Respond apart from the typically cold and sterile image of technological products.

"Respond’s new name, logo, and visual identity reflect our commitment to improving animal health and wellness through innovative solutions,” says Ryan DeCaire, CEO of Paw Prosper. “We believe our new identity better communicates our mission and the value we bring to the veterinary and animal care communities.”

The rebrand was led and designed by OffLeash Communications, a Charlotte-based agency known for building, rebranding, and stewarding many popular brand identities within the pet industry.

About Respond Animal Therapeutics

Since 1983, Respond Animal Therapeutics has been manufacturing top-of-the-line laser therapy and pulsed electromagnetic field (PEMF) therapy systems. Proudly made in the USA, with proven science and quality engineering, Respond Animal Therapeutics delivers the safest, most powerful, non-invasive pain management and rehabilitation solutions. Respond Animal Therapeutics is based in Branford, Connecticut, and was acquired by Paw Prosper in 2022. 

About Paw Prosper

Paw Prosper is focused on helping pets stay healthy, recover quickly, and age gracefully. Paw Prosper aims to provide industry experts and pet parents with the products, tools, and information they need to help pets overcome larger wellness challenges by focusing on genuinely efficacious solutions to the challenges of injury and aging. Paw Prosper was established in 2022 and is headquartered in Denver, Colorado, with additional offices in Toronto, Canada; Branford, Connecticut; Englewood, Florida; and the Netherlands.


Source: https://respondanimal.com/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Dr. Marjorie Bercier Publishes Study on Novel Diagnostic Approach for Prevalent Elephant Virus

Like0
Dislike0

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Like0
Dislike0

Feline injection site sarcomas

Like0
Dislike0

C-reactive protein concentrations in canine acute pancreatitis

Like0
Dislike0

A retrospective clinical investigation of the safety and adverse effects of pantoprazole in hospitalized ruminants

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top